ClinicalTrials.Veeva

Menu

Comparison of Botulinum Toxin Injection Techniques in Spasticity

K

Konya Beyhekim Training and Research Hospital

Status and phase

Not yet enrolling
Phase 4

Conditions

Spastic Hemiplegia

Treatments

Drug: Onabotulinumtoxina for Injection

Study type

Interventional

Funder types

Other

Identifiers

NCT05615987
2022-01-14

Details and patient eligibility

About

The aim of the study is to compare the effectiveness of the classical (2-4 points to the muscle proximal) application of botulinum toxin in the treatment of spasticity with the application along the length of the gastrecnemius muscle.

The main question it aims to answer Is botulinum toxin more effective in the treatment of spasticity than the classical application applied along the length of the gastrocnemius muscle? Participants will be evaluated for spasticity before and 1 month after injection.

Researchers will compare classical versus application along the length of the muscle to see if there is a reduction in spasticity.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with spastic hemiplegia
  • Spasticity in the gastrocnemius muscle

Exclusion criteria

  • Those who have spasticity in other muscles that will affect ankle movements
  • Those who use myorelaxant or myospasm-effective drugs
  • Those who have been applied botulinum toxin in the last 3 months
  • Those who have contractures in the ankle and knee due to orthopedic reasons.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Classic injection
Active Comparator group
Description:
200iu/2ml OnabotulinumtoxinA in total to 2-4 points proximal to the gastrocnemius muscle
Treatment:
Drug: Onabotulinumtoxina for Injection
İnjection along the length of the muscle
Experimental group
Description:
A total of 200iu/2ml of onabotulinumtoxinA by spreading along the length of the gastrocnemius muscle
Treatment:
Drug: Onabotulinumtoxina for Injection

Trial contacts and locations

1

Loading...

Central trial contact

Savaş Karpuz, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems